Hi and welcome to the A16Z podcast I'm Hannah. We're talking today about what is happening to oncology and to patients going through cancer treatment during the outbreak of coronavirus.

How treatment is affected, what kind of clinical decisions oncologists are having

to make, what kind of new tools, and what happens to oncology as a whole when it's forced in this moment

to go so virtual.

Joining myself and Venita Agarwala,

physician and general partner at A16Z,

are Dr. Bobby Green, community oncologist

and chief medical officer at Flat Iron Health, who is the first voice you'll hear,

and Dr. Sumit Shaw, oncologist and head of digital health at the Stanford Cancer

Center.

We're here today because coronavirus is now disrupting the entire health care system,

not just because of the burden of dealing with the actual disease itself, but because of everything else that's had to grind to a halt.

One of those areas where we really... everything else that's had to grind to a halt.

One of those areas where we really worry about things

coming to a total stop like that is, of course,

cancer treatment, which can often feel like a race

against the clock, even under the best conditions. So can we just

start by talking about the biggest issues that your cancer patients are facing

right now? I've been sort of I guess surprised how much more resilience I've actually seen among a lot of my

patients and maybe it's just because they've lived through so much uncertainty

and and gone through so much as part of their diagnoses that you know this is just one more

thing but I do think people have been remarkably resilient and in fact in some ways a

...